ログイン
言語:

WEKO3

  • トップ
  • コミュニティ
  • ランキング
AND
To
lat lon distance
To

Field does not validate



インデックスリンク

インデックスツリー

メールアドレスを入力してください。

WEKO

One fine body…

WEKO

One fine body…

アイテム

{"_buckets": {"deposit": "ac6d40ab-04e5-406c-96e0-1c6cf301fc55"}, "_deposit": {"id": "20089", "owners": [], "pid": {"revision_id": 0, "type": "depid", "value": "20089"}, "status": "published"}, "_oai": {"id": "oai:soar-ir.repo.nii.ac.jp:00020089", "sets": ["461:462"]}, "author_link": ["106234", "106235", "106236", "106237", "106238", "106239", "106240", "106241", "106242", "106243", "106244"], "item_1628147817048": {"attribute_name": "\u51fa\u7248\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"subitem_version_resource": "http://purl.org/coar/version/c_970fb48d4fbd8a85", "subitem_version_type": "VoR"}]}, "item_6_biblio_info_6": {"attribute_name": "\u66f8\u8a8c\u60c5\u5831", "attribute_value_mlt": [{"bibliographicIssueDates": {"bibliographicIssueDate": "2013-08-08", "bibliographicIssueDateType": "Issued"}, "bibliographicIssueNumber": "8", "bibliographicPageStart": "e70533", "bibliographicVolumeNumber": "8", "bibliographic_titles": [{"bibliographic_title": "PLOS ONE"}]}]}, "item_6_description_20": {"attribute_name": "\u6284\u9332", "attribute_value_mlt": [{"subitem_description": "Objectives\u003cbr/\u003eIncreased plasma C-reactive protein (CRP) levels are associated with the occurrence and severity of acute coronary syndrome. We investigated whether CRP can be generated in vascular endothelial cells (ECs) after exposure to the most electronegative subfraction of low-density lipoprotein (LDL), L5, which is atherogenic to ECs. Because L5 and CRP are both ligands for the lectin-like oxidized LDL receptor-1 (LOX-1), we also examined the role of LOX-1.\u003cbr/\u003eMethods and Results\u003cbr/\u003ePlasma LDL samples isolated from asymptomatic hypercholesterolemic (LDL cholesterol [LDL-C] levels, 154.6\u00b120 mg/dL; n\u200a=\u200a7) patients and normocholesterolemic (LDL-C levels, 86.1\u00b121 mg/dL; P\u003c0.001; n\u200a=\u200a7) control individuals were chromatographically resolved into 5 subfractions, L1-L5. The L5 percentage (L5%) and the plasma L5 concentration ([L5] \u200a=\u200a L5% \u00d7 LDL-C) in the patient and control groups were 8.1\u00b12% vs. 2.3\u00b11% (P\u003c0.001) and 12.6\u00b14 mg/dL vs. 1.9\u00b11 mg/dL (P\u003c0.001), respectively. In hypercholesterolemic patients treated with atorvastatin for 6 months (10 mg/day), [L5] decreased from 12.6\u00b14 mg/dL to 4.5\u00b11.1 mg/dL (P\u200a=\u200a0.011; n\u200a=\u200a5), whereas both [L5] and L5% returned to baseline levels in 2 noncompliant patients 3 months after discontinuation. In cultured human aortic ECs (HAECs), L5 upregulated CRP expression in a dose- and time-dependent manner up to 2.5-fold (P\u003c0.01), whereas the least electronegative subfraction, L1, had no effect. DiI-labeled L1, internalized through the LDL receptor, became visible inside HAECs within 30 seconds. In contrast, DiI-labeled L5, internalized through LOX-1, became apparent after 5 minutes. L5-induced CRP expression manifested at 30 minutes and was attenuated by neutralizing LOX-1. After 30 minutes, L5 but not L1 induced reactive oxygen species (ROS) production. Both L5-induced ROS and CRP production were attenuated by ROS inhibitor N-acetyl cysteine.\u003cbr/\u003eConclusions\u003cbr/\u003eOur results suggest that CRP, L5, and LOX-1 form a cyclic mechanism in atherogenesis and that reducing plasma L5 levels with atorvastatin disrupts the vascular toxicity of L5.", "subitem_description_type": "Abstract"}]}, "item_6_description_30": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7\uff08\u30b3\u30f3\u30c6\u30f3\u30c4\u306e\u7a2e\u985e\uff09", "attribute_value_mlt": [{"subitem_description": "Article", "subitem_description_type": "Other"}]}, "item_6_description_5": {"attribute_name": "\u5f15\u7528", "attribute_value_mlt": [{"subitem_description": "PLOS ONE.8(8):e70533(2013)", "subitem_description_type": "Other"}]}, "item_6_link_3": {"attribute_name": "\u4fe1\u5dde\u5927\u5b66\u7814\u7a76\u8005\u7dcf\u89a7\u3078\u306e\u30ea\u30f3\u30af", "attribute_value_mlt": [{"subitem_link_text": "Sawamura, Tatsuya", "subitem_link_url": "http://soar-rd.shinshu-u.ac.jp/profile/ja.HafpjeAF.html"}]}, "item_6_link_67": {"attribute_name": "WoS", "attribute_value_mlt": [{"subitem_link_text": "Web of Science", "subitem_link_url": "http://gateway.isiknowledge.com/gateway/Gateway.cgi?\u0026GWVersion=8\u0026SrcAuth=ShinshuUniv\u0026SrcApp=ShinshuUniv\u0026DestLinkType=FullRecord\u0026DestApp=WOS\u0026KeyUT=000323124000020"}]}, "item_6_publisher_4": {"attribute_name": "\u51fa\u7248\u8005", "attribute_value_mlt": [{"subitem_publisher": "PUBLIC LIBRARY SCIENCE"}]}, "item_6_relation_47": {"attribute_name": "PubMed", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "23950953"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://www.ncbi.nlm.nih.gov/pubmed/23950953", "subitem_relation_type_select": "PMID"}}]}, "item_6_relation_48": {"attribute_name": "DOI", "attribute_value_mlt": [{"subitem_relation_name": [{"subitem_relation_name_text": "10.1371/journal.pone.0070533"}], "subitem_relation_type_id": {"subitem_relation_type_id_text": "https://doi.org/10.1371/journal.pone.0070533", "subitem_relation_type_select": "DOI"}}]}, "item_6_rights_62": {"attribute_name": "\u6a29\u5229", "attribute_value_mlt": [{"subitem_rights": "\u00a9 2013 Chu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited."}]}, "item_6_select_64": {"attribute_name": "\u8457\u8005\u7248\u30d5\u30e9\u30b0", "attribute_value_mlt": [{"subitem_select_item": "publisher"}]}, "item_6_source_id_35": {"attribute_name": "ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1932-6203", "subitem_source_identifier_type": "PISSN"}]}, "item_6_source_id_39": {"attribute_name": "NII ISSN", "attribute_value_mlt": [{"subitem_source_identifier": "1932-6203", "subitem_source_identifier_type": "PISSN"}]}, "item_6_text_70": {"attribute_name": "wosonly keywords", "attribute_value_mlt": [{"subitem_text_value": "ACUTE CORONARY SYNDROMES; FIBROBLAST-GROWTH-FACTOR; STATIN THERAPY; LECTIN-LIKE; ATHEROSCLEROSIS; DISEASE; PREVENTION; RISK; INFLAMMATION; CHOLESTEROL"}]}, "item_6_textarea_68": {"attribute_name": "wosonly abstract", "attribute_value_mlt": [{"subitem_textarea_value": "Objectives: Increased plasma C-reactive protein (CRP) levels are associated with the occurrence and severity of acute coronary syndrome. We investigated whether CRP can be generated in vascular endothelial cells (ECs) after exposure to the most electronegative subfraction of low-density lipoprotein (LDL), L5, which is atherogenic to ECs. Because L5 and CRP are both ligands for the lectin-like oxidized LDL receptor-1 (LOX-1), we also examined the role of LOX-1. \u003cbr/\u003eMethods and Results: Plasma LDL samples isolated from asymptomatic hypercholesterolemic (LDL cholesterol [LDL-C] levels, 154.6 +/- 20 mg/dL; n = 7) patients and normocholesterolemic (LDL-C levels, 86.1 +/- 21 mg/dL; P \u003c 0.001; n = 7) control individuals were chromatographically resolved into 5 subfractions, L1-L5. The L5 percentage (L5%) and the plasma L5 concentration ([L5] = L5% x LDL-C) in the patient and control groups were 8.1 +/- 2% vs. 2.3 +/- 1% (P\u003c0.001) and 12.6 +/- 4 mg/dL vs. 1.9 +/- 1 mg/dL (P\u003c0.001), respectively. In hypercholesterolemic patients treated with atorvastatin for 6 months (10 mg/day), [L5] decreased from 12.664 mg/dL to 4.561.1 mg/dL (P = 0.011; n = 5), whereas both [L5] and L5% returned to baseline levels in 2 noncompliant patients 3 months after discontinuation. In cultured human aortic ECs (HAECs), L5 upregulated CRP expression in a dose- and time-dependent manner up to 2.5-fold (P \u003c 0.01), whereas the least electronegative subfraction, L1, had no effect. DiI-labeled L1, internalized through the LDL receptor, became visible inside HAECs within 30 seconds. In contrast, DiI-labeled L5, internalized through LOX-1, became apparent after 5 minutes. L5-induced CRP expression manifested at 30 minutes and was attenuated by neutralizing LOX-1. After 30 minutes, L5 but not L1 induced reactive oxygen species (ROS) production. Both L5-induced ROS and CRP production were attenuated by ROS inhibitor N-acetyl cysteine. \u003cbr/\u003eConclusions: Our results suggest that CRP, L5, and LOX-1 form a cyclic mechanism in atherogenesis and that reducing plasma L5 levels with atorvastatin disrupts the vascular toxicity of L5."}]}, "item_creator": {"attribute_name": "\u8457\u8005", "attribute_type": "creator", "attribute_value_mlt": [{"creatorNames": [{"creatorName": "Chu, CS", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106234", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Wang, YC", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106235", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Lu, LS", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106236", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Walton, B", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106237", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Yilmaz, HR", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106238", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Huang, RY", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106239", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Sawamura, T", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106240", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Dixon, RAF", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106241", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Lai, WT", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106242", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Chen, CH", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106243", "nameIdentifierScheme": "WEKO"}]}, {"creatorNames": [{"creatorName": "Lu, J", "creatorNameLang": "en"}], "nameIdentifiers": [{"nameIdentifier": "106244", "nameIdentifierScheme": "WEKO"}]}]}, "item_files": {"attribute_name": "\u30d5\u30a1\u30a4\u30eb\u60c5\u5831", "attribute_type": "file", "attribute_value_mlt": [{"accessrole": "open_date", "date": [{"dateType": "Available", "dateValue": "2018-09-12"}], "displaytype": "detail", "download_preview_message": "", "file_order": 0, "filename": "25293063_20.pdf", "filesize": [{"value": "3.9 MB"}], "format": "application/pdf", "future_date_message": "", "is_thumbnail": false, "licensefree": "\u00a9 2013 Chu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.", "licensetype": "license_note", "mimetype": "application/pdf", "size": 3900000.0, "url": {"label": "25293063_20.pdf", "url": "https://soar-ir.repo.nii.ac.jp/record/20089/files/25293063_20.pdf"}, "version_id": "cbdf0b85-b3c3-4d99-831c-fef2d177a8ed"}]}, "item_language": {"attribute_name": "\u8a00\u8a9e", "attribute_value_mlt": [{"subitem_language": "eng"}]}, "item_resource_type": {"attribute_name": "\u8cc7\u6e90\u30bf\u30a4\u30d7", "attribute_value_mlt": [{"resourcetype": "journal article", "resourceuri": "http://purl.org/coar/resource_type/c_6501"}]}, "item_title": "Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor", "item_titles": {"attribute_name": "\u30bf\u30a4\u30c8\u30eb", "attribute_value_mlt": [{"subitem_title": "Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor", "subitem_title_language": "en"}]}, "item_type_id": "6", "owner": "1", "path": ["461/462"], "permalink_uri": "http://hdl.handle.net/10091/00020850", "pubdate": {"attribute_name": "PubDate", "attribute_value": "2018-09-12"}, "publish_date": "2018-09-12", "publish_status": "0", "recid": "20089", "relation": {}, "relation_version_is_last": true, "title": ["Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor"], "weko_shared_id": -1}
  1. 050 医学部, 大学院医学系研究科
  2. 0501 学術論文

Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor

http://hdl.handle.net/10091/00020850
419b5a64-e5ba-4438-a2a1-5b8212b490bc
名前 / ファイル ライセンス アクション
25293063_20.pdf 25293063_20.pdf (3.9 MB)
Item type 学術雑誌論文 / Journal Article(1)
公開日 2018-09-12
タイトル
言語 en
タイトル Electronegative Low-Density Lipoprotein Increases C-Reactive Protein Expression in Vascular Endothelial Cells through the LOX-1 Receptor
言語
言語 eng
資源タイプ
資源 http://purl.org/coar/resource_type/c_6501
タイプ journal article
著者 Chu, CS

× Chu, CS

WEKO 106234

en Chu, CS

Search repository
Wang, YC

× Wang, YC

WEKO 106235

en Wang, YC

Search repository
Lu, LS

× Lu, LS

WEKO 106236

en Lu, LS

Search repository
Walton, B

× Walton, B

WEKO 106237

en Walton, B

Search repository
Yilmaz, HR

× Yilmaz, HR

WEKO 106238

en Yilmaz, HR

Search repository
Huang, RY

× Huang, RY

WEKO 106239

en Huang, RY

Search repository
Sawamura, T

× Sawamura, T

WEKO 106240

en Sawamura, T

Search repository
Dixon, RAF

× Dixon, RAF

WEKO 106241

en Dixon, RAF

Search repository
Lai, WT

× Lai, WT

WEKO 106242

en Lai, WT

Search repository
Chen, CH

× Chen, CH

WEKO 106243

en Chen, CH

Search repository
Lu, J

× Lu, J

WEKO 106244

en Lu, J

Search repository
信州大学研究者総覧へのリンク
氏名 Sawamura, Tatsuya
URL http://soar-rd.shinshu-u.ac.jp/profile/ja.HafpjeAF.html
出版者
出版者 PUBLIC LIBRARY SCIENCE
引用
内容記述タイプ Other
内容記述 PLOS ONE.8(8):e70533(2013)
書誌情報 PLOS ONE

巻 8, 号 8, p. e70533, 発行日 2013-08-08
抄録
内容記述タイプ Abstract
内容記述 Objectives<br/>Increased plasma C-reactive protein (CRP) levels are associated with the occurrence and severity of acute coronary syndrome. We investigated whether CRP can be generated in vascular endothelial cells (ECs) after exposure to the most electronegative subfraction of low-density lipoprotein (LDL), L5, which is atherogenic to ECs. Because L5 and CRP are both ligands for the lectin-like oxidized LDL receptor-1 (LOX-1), we also examined the role of LOX-1.<br/>Methods and Results<br/>Plasma LDL samples isolated from asymptomatic hypercholesterolemic (LDL cholesterol [LDL-C] levels, 154.6±20 mg/dL; n = 7) patients and normocholesterolemic (LDL-C levels, 86.1±21 mg/dL; P<0.001; n = 7) control individuals were chromatographically resolved into 5 subfractions, L1-L5. The L5 percentage (L5%) and the plasma L5 concentration ([L5]  =  L5% × LDL-C) in the patient and control groups were 8.1±2% vs. 2.3±1% (P<0.001) and 12.6±4 mg/dL vs. 1.9±1 mg/dL (P<0.001), respectively. In hypercholesterolemic patients treated with atorvastatin for 6 months (10 mg/day), [L5] decreased from 12.6±4 mg/dL to 4.5±1.1 mg/dL (P = 0.011; n = 5), whereas both [L5] and L5% returned to baseline levels in 2 noncompliant patients 3 months after discontinuation. In cultured human aortic ECs (HAECs), L5 upregulated CRP expression in a dose- and time-dependent manner up to 2.5-fold (P<0.01), whereas the least electronegative subfraction, L1, had no effect. DiI-labeled L1, internalized through the LDL receptor, became visible inside HAECs within 30 seconds. In contrast, DiI-labeled L5, internalized through LOX-1, became apparent after 5 minutes. L5-induced CRP expression manifested at 30 minutes and was attenuated by neutralizing LOX-1. After 30 minutes, L5 but not L1 induced reactive oxygen species (ROS) production. Both L5-induced ROS and CRP production were attenuated by ROS inhibitor N-acetyl cysteine.<br/>Conclusions<br/>Our results suggest that CRP, L5, and LOX-1 form a cyclic mechanism in atherogenesis and that reducing plasma L5 levels with atorvastatin disrupts the vascular toxicity of L5.
資源タイプ(コンテンツの種類)
内容記述タイプ Other
内容記述 Article
ISSN
収録物識別子タイプ PISSN
収録物識別子 1932-6203
PubMed
関連識別子
識別子タイプ PMID
関連識別子 https://www.ncbi.nlm.nih.gov/pubmed/23950953
関連名称
関連名称 23950953
DOI
関連識別子
識別子タイプ DOI
関連識別子 https://doi.org/10.1371/journal.pone.0070533
関連名称
関連名称 10.1371/journal.pone.0070533
権利
権利情報 © 2013 Chu et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
出版タイプ
出版タイプ VoR
出版タイプResource http://purl.org/coar/version/c_970fb48d4fbd8a85
WoS
表示名 Web of Science
URL http://gateway.isiknowledge.com/gateway/Gateway.cgi?&GWVersion=8&SrcAuth=ShinshuUniv&SrcApp=ShinshuUniv&DestLinkType=FullRecord&DestApp=WOS&KeyUT=000323124000020
戻る
0
views
See details
Views

Versions

Ver.1 2021-03-01 08:15:19.482779
Show All versions

Share

Mendeley CiteULike Twitter Facebook Print Addthis

Cite as

Export

OAI-PMH
  • OAI-PMH JPCOAR
  • OAI-PMH DublinCore
  • OAI-PMH DDI
Other Formats
  • JSON
  • BIBTEX

Confirm


Powered by CERN Data Centre & Invenio


Powered by CERN Data Centre & Invenio